{"id":1470561,"title":"DSEN Abstract: High potency statins and the risk of new diabetes - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-07","captureTimestamp":"2026-04-07T17:45:33.602000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/49225.html?wbdisable=true","snippet":"DSEN Abstract High potency statins and the risk of new diabetes This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Colin R. Dormuth, Kristian B. Filion, J. Michael Paterson, Matthew T. James, Gary F. Teare,…","rawSnapshotUrl":"/api/snapshots/raw/1470561","browseUrl":"https://replay.healtharchive.ca/job-8/20260407174533/https://cihr-irsc.gc.ca/e/49225.html?wbdisable=true#ha_snapshot=1470561","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}